Immunovia AB (OSTO:IMMNOV)
kr 0.618 -0.01 (-1.59%) Market Cap: 104.88 Mil Enterprise Value: 76.83 Mil PE Ratio: 0 PB Ratio: 2.91 GF Score: 44/100

Immunovia AB (publ) Corporate Analyst Meeting Transcript

Jun 30, 2020 / 12:00PM GMT
Release Date Price: kr72.11 (+6.98%)
Julie Silber;publ;Director of IR
Immunovia AB

()-

Welcome and thank you for joining Immunovia's Investor Day. My name is Julie Silber, and I am the Investor Relations Director here at Immunovia, and I will be the moderator for today's event. Today's event is truly virtual with some of our presenters in Lund and some calling in from their home offices in the U.S. As a result, you may only see those who are in Lund, but you will see the slide deck from all of us. (Operator Instructions)

Now I will take a moment to briefly remind everyone of our forward-looking statements, which can be found on our website as well. The following applies to this document, the oral presentation

(technical difficulty)

and any question-and-answer session that follows the oral presentation, collectively, the information.

The information has been prepared and issued by the company solely for use of this presentation held by the company in relation to the company's operations and position. The information has not been independently verified and will not be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot